Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

RTW Biotech portfolio co Aktis Oncology raises $318m in IPO

(Sharecast News) - Life sciences investor RTW Biotech Opportunities said its private portfolio company Aktis Oncology had raised $318m via an IPO. Aktis offered 17.65 million shares at $18 each, representing a 2.6% step-up from RTW Bio's prior holding value at November 30 and a18.3% step-up from the cost at the time of purchase in September 2024.

Aktis started trading on the Nasdaq global select market on January 9, where the stock traded up 24.4% to close at $22.40 per share.

The clinical-stage oncology company is focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations. Its lead programme targets Nectin-4, a miniprotein radioconjugate with multi-indication potential across multiple tumour types, RTW said on Monday.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

Magnum Ice Cream results fail to impress as operating profit slides
(Sharecast News) - Shares in Magnum Ice Cream tumbled on Thursday as its first full-year results since the recent demerger from Unilever failed to impress.
THG strikes deal with Greencore to sell protein-enriched convenience foods
(Sharecast News) - THG is to target the booming obesity jab market through a strategic partnership with convenience food producer Greencore Group, it confirmed on Thursday.
RBC Capital Markets lowers target price on Barratt Redrow
(Sharecast News) - Analysts at RBC Capital Markets lowered their target price on property developer Barratt Redrow from 450p to 425p on Thursday as it updated its estimates to account for the firm's interim results.
GPE secures major pre‑let at The Delft with AI firm Quantexa
(Sharecast News) - Property developer Great Portland Estates has pre-let of 52,293 square feet at The Delft, SE1 to global data, analytics, and AI software company Quantexa.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.